Metyos
PrivateLast Round
Pre Seed
Mar 26, 2024
Total Funding Raised
$4.99M
Company Overview
Metyos is a medtech company that develops a biowearable sensor and disease management platform for continuous monitoring of patients with chronic kidney disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Patient Engagement, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Metyos Comparables
Compare Metyos with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Proton Intelligence | 91% | |
| Kalium Health | 88% | |
| mTatt | 74% | |
Metyos Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Mar 26, 2024 | ||||
| Pre Seed | Mar 26, 2024 |
Key People
Founding team and executive leadership
Metyos Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kima Ventures | Pre Seed |
| Advans Lab | Pre Seed |
| Bpifrance | Pre Seed |
| Cenitz | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 26, 2024
$2.5M round led by Cenitz
Metyos Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Metyos's valuation, stock price, and market status.